Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |